---

November 13, 2008

Ranbaxy-Daiichi Deal Dissected

Dear All,

With the completion of acquisition of 63.92% equity stake in Ranbaxy Laboratories Limited (“Ranbaxy”), India's largest pharmaceutical company, by Japanese pharma major Daiichi Sankyo Co., Ltd. (“Daiichi”), on November 7, 2008, it would be interesting to analyze the key legal and tax issues that arose from the beginning till the completion of this landmark deal.

---

For a detailed analysis of the legal and tax issues, please click here for the document.

---

As you would be aware, we have been providing regular information on latest legal developments. M&A Lab is our latest initiative to provide you in depth and knowledge based analysis of latest M&A deals. We will be happy to have your views / comments on our initiative.

– Ruchi Biyani, Vaidhyanadhan Iyer & Nishchal Joshipura 
You can direct your queries or comments to Team M&A